Farid Ramy insider trades
Farid Ramy has filed 12 Form 4s with the SEC that we hold, for Schrodinger, Inc. (SDGR) (President & CEO, Director), Vir Biotechnology, Inc. (VIR) (Director) and Structure Therapeutics Inc. (GPCR) (Director). Across all of them we count 0 purchases worth $0 and 5 sales worth $2.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($1.2M). The largest single trade was a sale of 66,886 shares of Schrodinger, Inc. worth $1.2M, dated 2023-01-04. The first filing on our record is dated 2022-02-09 and the latest 2026-05-28.
Schrodinger, Inc. (SDGR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-01-04 | S, sale reported on Form 4 | 66,886 | $1.2M | 2023-01-05 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 5,560 | $66.2K | 2026-03-03 | SEC |
| 2026-03-05 | S, sale reported on Form 4 | 3,661 | $47.3K | 2026-03-06 | SEC |
| 2026-04-16 | S, sale reported on Form 4 | 43,000 | $530.2K | 2026-04-17 | SEC |
| 2026-04-17 | S, sale reported on Form 4 | 43,000 | $525.0K | 2026-04-17 | SEC |
Vir Biotechnology, Inc. (VIR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Structure Therapeutics Inc. (GPCR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1797707) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
